跳至主要内容
临床试验/NCT05195034
NCT05195034
招募中
不适用

Effect of Dexmedetomidine on Postoperative Delirium in Patients Undergoing Awake Craniotomies: a Randomized Controlled Trial

Beijing Tiantan Hospital1 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2022年3月31日最近更新:

概览

阶段
不适用
状态
招募中
发起方
Beijing Tiantan Hospital
入组人数
210
试验地点
1
主要终点
The incidence of postoperative delirium.

概览

简要总结

Postoperative delirium (POD) is a common complication, and the incidence of POD ranges from 10% to 60%. Previous studies suggested that frontal approach and tumor located at the temporal lobe were independent risk factors for POD after supratentorial tumor resections. Therefore, patients undergoing awake craniotomies are high-risk populations for POD. A lot of trials show that dexmedetomidine might help to reduce the incidence of delirium in patients undergoing non-cardiac surgery. However, the impact of dexmedetomidine (DEX) on POD for patients undergoing awake craniotomies remains unclear. The purpose of this study was to investigate the effect of DEX on POD in patients undergoing awake craniotomies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing selective awake craniotomies.
  • Age ≥18 years.
  • Obtain written informed consent.

排除标准

  • 1.Preoperative moderate and severe cognitive impairment (Montreal Cognitive Assessment, MoCA\< 18).
  • 2.Preoperative psychotropic medication within one year.
  • 3.BMI≤18 or ≥30 Kg/ m2
  • 4.Pregnant or lactating women.
  • 5.History of traumatic brain injury or neurosurgery.
  • 6.Severe bradycardia (heart rate less than 40 beats per minute), sick sinus syndrome or second-to-third degree atrioventricular block.
  • 7.Severe hepatic or renal dysfunction.

研究组 & 干预措施

Placebo group

Placebo Comparator

The placebo group patients will be received 0.9% saline intraoperatively.

干预措施: 0.9% saline (Drug)

DEX group

Active Comparator

The DEX group patients will be received dexmedetomidine intraoperatively.

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

The incidence of postoperative delirium.

时间窗: postoperative 5 day.

postoperative delirium is assessed by the combination of the Richmond Anxiety Scale (RASS) and the Confusion assessment method for intensive care unit (CAM-ICU) or the 3-minute diagnostic interview for CAM (3D-CAM) as applicable.

次要结局

未报告次要终点

研究者

发起方
Beijing Tiantan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuming Peng

Deputy chief of Department of Anesthesiology

Beijing Tiantan Hospital

研究点 (1)

Loading locations...

相似试验